Clinical Trials Directory

Trials / Unknown

UnknownNCT04610983

Omega-3 Bioavailability From Vegetable-omega-3 Enriched Products

Bioavailability of Omega-3 Long-chain Polyunsaturated Fatty Acids (LCPUFA) From Foods Enriched With Vegetable-encapsulated Omega-3 Oils

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Commonwealth Scientific and Industrial Research Organisation, Australia · Other Government
Sex
Male
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

CSIRO's Food Program has developed a novel vegetable-based Omega-3 long-chain polyunsaturated fatty acid (Omega 3)encapsulant to be used as ingredient in various food products, however, it is unknown whether the vegetable-based carrier matrix will affect omega-3 bioavailability. This project aims to compare the bioavailability of omega-3 from two test foods containing vegetable (cauliflower)-encapsulated algal oil (the "ingredient") against a control test product (algal oil gel capsules) across two ethnicities (Australian European vs. Chinese Singaporean).

Detailed description

Omega-3 long-chain polyunsaturated fatty acids (omega-3) (eicosapentaenoic acid \[EPA\] and docosahexaenoic acid \[DHA\]) is associated with many health benefits including improved brain, heart, joint and eye health. However, \<20% of the world's population consume adequate amounts of these fatty acids. Individuals who don't consume fish (major dietary omega-3 source) and particularly vegans/vegetarians are at greatest risk of omega-3 deficiency. Convenient strategies empowering consumers to increase their omega-3 intake have potential to significantly impact health outcomes. CSIRO's Food Program has developed a novel vegetable-based omega-3 encapsulant to be used as ingredient in various food products. Using algal oil as omega-3 source provides vegan/vegetarian options. However, it is unknown whether the vegetable-based carrier matrix will affect omega-3 bioavailability. As these products are intended for global markets, it is also unknown whether ethnic differences may affect omega-3 bioavailability. This project forms part of a larger project aiming to develop sensorially and culturally acceptable food products that incorporate vegetable-encapsulated omega-3 oils to assist Australian and Singaporean consumers to achieve their omega-3 LCPUFA intake. This component of the project aims to compare the bioavailability of omega-3 from two test foods containing vegetable (cauliflower)-encapsulated algal oil (the "ingredient") against a control test product (algal oil gel capsules) across two ethnicities (Australian European vs. Chinese Singaporean). To achieve this, two clinical trials, following the same protocol, will be executed in both Australia (Australian European) and Singapore (Chinese Singaporean).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental: Control2 x algal oil gel capsules delivering 400mg DHA in total
DIETARY_SUPPLEMENTExperimental: Treatment 1 - Semi-Solid food matrixTest Food 1: 200g serve soup + "ingredient"
DIETARY_SUPPLEMENTTreatment 2 - Solid food matrixTest Food 2: 50g serve extruded snack (savoury snack) + "ingredient"

Timeline

Start date
2020-11-16
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2020-11-02
Last updated
2020-11-02

Locations

2 sites across 2 countries: Australia, Singapore

Source: ClinicalTrials.gov record NCT04610983. Inclusion in this directory is not an endorsement.